Lōkahi Therapeutics Launches Qare Comparative Health Platform

Glucotrack subsidiary Lōkahi Therapeutics announced the public launch of Qare, a platform for comparing self-reported treatment experiences across medications in the same therapeutic class. It is launching initially with GLP-1 medications.